Skip to main content
. 2016 Sep 8;7(43):69616–69624. doi: 10.18632/oncotarget.11903

Figure 3. Kaplan-Meier survival curves for PC patients with high and low risk score in subgroup analyses according to different treatment modalities.

Figure 3

MTT: molecular targeted therapy.